BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAD3.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $95,967,000 | +6.0% | 22,379,000 | 0.0% | 0.78% | -11.5% |
| Q4 2016 | $90,531,000 | -10.7% | 22,379,000 | 0.0% | 0.89% | -3.6% |
| Q3 2016 | $101,405,000 | +19.4% | 22,379,000 | 0.0% | 0.92% | +3.4% |
| Q2 2016 | $84,908,000 | -5.5% | 22,379,000 | 0.0% | 0.89% | -6.0% |
| Q1 2016 | $89,825,000 | -22.0% | 22,379,000 | 0.0% | 0.95% | -0.7% |
| Q4 2015 | $115,158,000 | -0.4% | 22,379,000 | 0.0% | 0.95% | -10.7% |
| Q3 2015 | $115,619,000 | -22.9% | 22,379,000 | 0.0% | 1.07% | -18.8% |
| Q2 2015 | $149,970,000 | +9.5% | 22,379,000 | 0.0% | 1.32% | +15.5% |
| Q1 2015 | $136,987,000 | +34.2% | 22,379,000 | -2.3% | 1.14% | +9.3% |
| Q4 2014 | $102,104,000 | +25.5% | 22,898,000 | 0.0% | 1.04% | +1.7% |
| Q3 2014 | $81,355,000 | +15.4% | 22,898,000 | 0.0% | 1.02% | +18.6% |
| Q2 2014 | $70,511,000 | -8.6% | 22,898,000 | 0.0% | 0.86% | -11.8% |
| Q1 2014 | $77,127,000 | -2.8% | 22,898,000 | 0.0% | 0.98% | -12.4% |
| Q4 2013 | $79,367,000 | -3.2% | 22,898,000 | 0.0% | 1.12% | -4.0% |
| Q3 2013 | $82,032,000 | +29.8% | 22,898,000 | 0.0% | 1.17% | -6.7% |
| Q2 2013 | $63,217,000 | – | 22,898,000 | – | 1.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|